NovMetaPharma Co., Ltd. (XKON:229500)
South Korea
· Delayed Price · Currency is KRW
15,000
0.00 (0.00%)
At close: Aug 14, 2025, 3:30 PM KST
NovMetaPharma Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2014 | FY 2013 |
| Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 |
| Net Income | 408.03 | 19.62 |
| Depreciation & Amortization | 48.18 | 31.88 |
| Loss (Gain) From Sale of Investments | -417.3 | - |
| Provision & Write-off of Bad Debts | -1.4 | - |
| Other Operating Activities | -44.09 | 18.52 |
| Change in Accounts Receivable | 140 | -138.6 |
| Change in Inventory | -447.31 | 202.24 |
| Change in Accounts Payable | 42.6 | 18.65 |
| Change in Other Net Operating Assets | 91.93 | 12.43 |
| Operating Cash Flow | -179.36 | 164.74 |
| Capital Expenditures | -84.45 | -0.48 |
| Sale (Purchase) of Intangibles | -0.62 | -3.79 |
| Investment in Securities | -582.7 | - |
| Other Investing Activities | -768.17 | -453.43 |
| Investing Cash Flow | -1,436 | -457.7 |
| Issuance of Common Stock | 2,703 | 1,360 |
| Financing Cash Flow | 2,703 | 1,360 |
| Miscellaneous Cash Flow Adjustments | 0 | -0 |
| Net Cash Flow | 1,087 | 1,067 |
| Free Cash Flow | -263.81 | 164.26 |
| Free Cash Flow Margin | -20.36% | 15.39% |
| Free Cash Flow Per Share | -77.58 | 58.60 |
| Levered Free Cash Flow | 268.76 | - |
| Unlevered Free Cash Flow | 268.76 | - |
| Change in Working Capital | -172.78 | 94.71 |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.